Tumor Hypoxia and Systemic Levels of Vascular Endothelial Growth Factor (VEGF) in Head and Neck Cancers
✍ Scribed by Jürgen Dunst; Peter Stadler; Axel Becker; Thomas Kuhnt; Christine Lautenschläger; Michael Molls; Gabriele Haensgen
- Publisher
- Springer
- Year
- 2001
- Tongue
- German
- Weight
- 116 KB
- Volume
- 177
- Category
- Article
- ISSN
- 0179-7158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Angiogenesis is a necessary process for tumor progression and is driven through molecular interactions between cancer cells and neighboring vascular endothelial cells. The primary mediators of angiogenesis are the vascular endothelial growth factors and their respective receptors on end
## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (flt‐4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph